Compounds > pozanicline
Page last updated: 2024-09-03

pozanicline and Cognition Disorders

pozanicline has been researched along with Cognition Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Childress, A; Sallee, FR1
Anderson, DJ; Briggs, CA; Buckley, MJ; Cox, BF; Decker, MW; Donnelly-Roberts, DL; Gintant, GA; Gopalakrishnan, M; Lin, NH; Martin, RL; McDermott, JS; Osinski, MA; Preusser, LC; Reinhart, GA; Rueter, LE; Seifert, TR; Su, Z; Sullivan, JP1

Reviews

2 review(s) available for pozanicline and Cognition Disorders

ArticleYear
Pozanicline for the treatment of attention-deficit/hyperactivity disorder.
    Expert opinion on investigational drugs, 2014, Volume: 23, Issue:11

    Topics: Adolescent; Adult; Animals; Attention Deficit Disorder with Hyperactivity; Child; Cognition Disorders; Drug Design; Drug Partial Agonism; Humans; Nicotinic Agonists; Pyridines; Pyrrolidines; Receptors, Nicotinic

2014
ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders.
    CNS drug reviews, 2004,Summer, Volume: 10, Issue:2

    Topics: Animals; Cardiovascular System; Cognition Disorders; Digestive System; Dogs; Dose-Response Relationship, Drug; Humans; Learning; Mice; Nicotinic Agonists; Pyridines; Pyrrolidines; Rats

2004